NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹365 Cr | ₹333 Cr | ₹301 Cr | ₹278 Cr | ₹13,770,298 Cr |
What is the latest Revenue of NATH BIOGENES (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹365 Cr |
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹301 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹13,770,298 Cr |
How is Revenue of NATH BIOGENES (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹365 Cr | 9.71 | |
| Mar2025 | ₹333 Cr | 10.37 | |
| Mar2024 | ₹301 Cr | 8.26 | |
| Mar2023 | ₹278 Cr | -100.00 | |
| Mar2022 | ₹13,770,298 Cr | - | |
Compare Revenue of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹271.5 Cr | -3% | -6.5% | -12.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,824.0 Cr | 4.9% | -5.6% | -32.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,300.0 Cr | -3.6% | 3.8% | 9.1% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,404.5 Cr | -4.9% | 7.6% | 17.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹883.9 Cr | -3.5% | -7.3% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹531.2 Cr | 4.5% | 11.3% | -2.3% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -3% |
-6.5% |
-12.5% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses